Thomas N G Handley (Thomas Handley)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Systemic Sclerosis

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

ACS pharmacology & translational science

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Akhter Hossain, Praveen Praveen, Nurhayati Ahmad Noorzi, Hongkang Wu, Ian P Harrison, Thomas N G Handley, Stavros Selemidis, Chrishan S Samuel, Ross A D Bathgate
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1. ACS pharmacology & translational science 6 (5) (2023)
Mohammed Akhter Hossain, Praveen Praveen, Nurhayati Ahmad Noorzi, Hongkang Wu, Ian P Harrison, Thomas N G Handley, Stavros Selemidis, Chrishan S Samuel, Ross A D Bathgate
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1. ACS pharmacology & translational science 6 (5) (2023)
Mohammed Akhter Hossain, Praveen Praveen, Nurhayati Ahmad Noorzi, Hongkang Wu, Ian P Harrison, Thomas N G Handley, Stavros Selemidis, Chrishan S Samuel, Ross A D Bathgate
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1. ACS pharmacology & translational science 6 (5) (2023)
Bruce Lin, Rong Li, Thomas N G Handley, John D Wade, Wenyi Li, Neil M O'Brien-Simpson
Cationic Antimicrobial Peptides Are Leading the Way to Combat Oropathogenic Infections. ACS infectious diseases 7 (11) (2021)